Here Is What to Know Beyond Why Pfizer Inc. (PFE) Is a Trending Stock
Pfizer (NYSE:PFE) Is Paying Out A Larger Dividend Than Last Year
Why Pfizer (PFE) Is One of the Best Cheap Stocks to Buy for 2025?
Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32
Pfizer Options Spot-On: On January 17th, 154.73K Contracts Were Traded, With 3.33 Million Open Interest
U.S. Gives Moderna $590 Million to Accelerate Bird Flu Vaccine -- Barrons.com
Weekly Buzz: Finally a Good Week for 2025
Odyssey Therapeutics Files for $100M IPO
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Pfizer Reduces Stake in Haleon Through Share Sale
Trump Is a 'Wild Card' for the Stock Market, This Trader Says. He's Buckling Up.
Express News | EMA: Supply Shortage With Zirabev in the EU From Sept 2, 2024
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
Pfizer Believes in the Metaverse: Will Healthcare Thaw the Technology's Winter?
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Express News | 'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Pre-market drop of over 4%! Novo-Nordisk A/S's "weight loss miracle drug" enters price negotiations with USA healthcare.
The diabetes drug Ozempic and the weight loss drug Wegovy, among 15 other medications from Novo-Nordisk A/S, have been included in the USA government’s plan for Medicare price negotiations scheduled for 2027. After this announcement, Novo-Nordisk A/S's stock price was surpassed by LVMH, making it the second largest publicly traded company in Europe.
Medicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out. -- Barrons.com
Express News | U.S. Health Secretary: Drugs Targeted Are Too Expensive and Should Be Lowered in Price -Cnn Interview
Express News | U.S. Says Other Drugs on Medicare Drug Price List Include Pomalyst, Ibrance and Calquence